The UK Health Security Agency reported that a meningitis outbreak has passed its peak, though officials continue monitoring for additional cases. The agency indicated that while the worst appears to be over, surveillance remains necessary as new infections could still emerge.

Separately, pharmaceutical company Pfizer announced that its long-awaited Lyme disease vaccine demonstrated effectiveness in clinical trials. The vaccine represents a significant development in preventing Lyme disease, a tick-borne illness that affects thousands annually.

In another medical advancement, Bausch + Lomb released pivotal clinical data for its ELIOS System, a treatment device designed for glaucoma patients. The company unveiled the results as part of ongoing development of the therapeutic system.

These developments reflect ongoing progress across multiple areas of public health, from infectious disease outbreaks to preventive vaccines and specialized medical devices. Health authorities continue to monitor the meningitis situation while pharmaceutical companies advance new treatments through clinical development processes.